TX HB3455

Defines "experimental drug or device" as any drug or device that is experimental, investigational, or has been approved by the FDA for emergency use

Requires manufacturers of experimental drugs or devices to provide purchasers with a disclosure form containing all information necessary for informed consumer decisions, including possible adverse health effects, in a clear and coherent summary

Mandates that purchasers pass the disclosure form along the supply chain, with health care providers and retailers required to deliver the form in person and obtain a signed consent from someone capable of providing informed consent before selling to consumers

Creates a private right of action allowing consumers who receive experimental drugs or devices without proper disclosure to sue the manufacturer for damages arising from adverse effects

Allows prevailing claimants to recover compensatory damages (including pain and suffering), exemplary damages, and reasonable attorney's fees and costs; effective September 1, 2025